1st Mini-Symposium on Proteomics

Explore the Fascinating World of Proteomics

Asia/Qatar 1st Mini-Symposium on Proteomics Qatar National Library Research Proteomics Core doj2006@qatar-med.cornell.edu AT Qatar National Library

Karsten Suhre, PhD

Karsten Suhre
Professor of Physiology and Biophysics
Director of the Bioinformatics Core
Weill Cornell Medicine-Qatar
Doha, Qatar

Dr. Karsten Suhre joined Weill Cornell Medicine-Qatar (WCM-Q) in March 2011 as Professor of Physiology and Biophysics and Director of the Bioinformatics Core.

From 2006 until joining WCM-Q, Dr. Suhre served as Professor in the Department of Biology at Ludwig-Maximilians-University in Munich (LMU), Germany. During that time, he also served as Group Leader for Metabolomics Research at the Institute for Bioinformatics and Systems Biology, Helmholtz Zentrum München, German Research Centre for Environmental Health. Before 2006, Dr. Suhre worked at the French National Centre for Scientific Research (CNRS) as a Director of Research.

Dr. Suhre's research interests focus on metabolomics and genetic epidemiology, bioinformatics, functional and structural biology. On these subjects, Dr. Suhre has taught multiple courses, published over seventy articles in peer-reviewed journals, and delivered numerous international presentations. 

Prior to joining WCM-Q, Dr. Suhre established the field of genome-wide association study of human metabolism, which is reflected in several high-impact publications in the field of which he is the senior author.

As a faculty member of WCM-Q since March 2011, Dr. Suhre’s now studies how genetic variation in human metabolism interacts with environmental challenges and lifestyle factors in the development of complex diseases, including diabetes, heart and kidney diseases. Knowledge of the genetic basis of metabolic individuality in humans generates many new hypotheses for biomedical and pharmaceutical research, and potentially informs individualized therapy. 

He is currently involved in setting up clinical studies in cooperation with different health organizations in Qatar, including diabetes and ovarian cancer, which centrally involve his specific knowledge in the field of metabolomics.